• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The prognostic significance of functional tests in cryptogenic fibrosing alveolitis.

作者信息

Jezek V, Fucik J, Michaljanic A, Jezkova L

出版信息

Bull Eur Physiopathol Respir. 1980 Nov-Dec;16(6):711-20.

PMID:7448462
Abstract

Fifty-six patients with kryptogenic fibrosing alveolitis were followed up during 6.3 years (from 1.5 to 19.3 years) after their first functional examination including cardiac catheterization. Twenty-two out of 56 patients died during the follow-up. The significance of individual functional tests as predictors of the survival was evaluated by means of actuarial survival probability curves. Four variables were predictive for nonsurvival: a mean pulmonary arterial pressure exceeding 30 mmHg, a vital capacity of 60% of the predicted value or lower, a CO diffusing capacity at rest less than 40% of the predicted value, an age at first symptoms over 30 years. Other variables were not significantly predictive for a given time of follow-up. A simple prognostic score derived from predictive variables was able to separate the subgroup of patients with unfavourable short-term prognosis. Among significantly predictive variables, a resting pulmonary arterial pressure over 30 mmHg appears to be the most important.

摘要

相似文献

1
The prognostic significance of functional tests in cryptogenic fibrosing alveolitis.
Bull Eur Physiopathol Respir. 1980 Nov-Dec;16(6):711-20.
2
Long-term development of pulmonary hypertension in cryptogenic fibrosing alveolitis.
Cor Vasa. 1980;22(4):245-50.
3
[Long-term changes of some ventilatory and respiratory functions in cryptogenic fibrosing alveolitis (author's transl)].
Cas Lek Cesk. 1974 Sep 6;113(36):1091-4.
4
The prognosis and development of pulmonary hypertension in idiopathic diffuse interstitial lung fibrosis.
G Ital Cardiol. 1984;14 Suppl 1:39-45.
5
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.N 端脑钠肽前体(N-TproBNP)在硬皮病相关肺动脉高压中的作用
Eur Heart J. 2006 Jun;27(12):1485-94. doi: 10.1093/eurheartj/ehi891. Epub 2006 Apr 27.
6
[Natural history of atrial septal defect with pulmonary hypertension: follow-up of medically treated patients over 16 years of age].[房间隔缺损合并肺动脉高压的自然病史:16岁以上接受药物治疗患者的随访]
J Cardiol. 1994 Mar-Apr;24(2):107-13.
7
[The prognostic significance of pulmonary arterial hypertension in chronic obstructive airway disease (author's transl)].慢性阻塞性气道疾病中肺动脉高压的预后意义(作者译)
Poumon Coeur. 1981;37(3):177-84.
8
Long-term prognosis of pulmonary hypertension in silicosis.
Cor Vasa. 1980;22(4):221-37.
9
[The prognostic value of haemodynamic tests in chronic bronchitis (author's transl)].血流动力学检查在慢性支气管炎中的预后价值(作者译)
Bull Eur Physiopathol Respir. 1979 Sep-Oct;15(5):821-37.
10
[Retrospective study of 50 cases of idiopathic fibrosing alveolitis with catamnesis].
Schweiz Med Wochenschr. 1979 Aug 18;109(31):1154-61.

引用本文的文献

1
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review.特发性肺纤维化患者未接受抗纤维化治疗的预后:一项系统评价。
Eur Respir Rev. 2020 Aug 4;29(157). doi: 10.1183/16000617.0158-2019. Print 2020 Sep 30.
2
Relevance analysis of clinical and lung function parameters changing and prognosis of idiopathic pulmonary fibrosis.特发性肺纤维化临床及肺功能参数变化与预后的相关性分析
Int J Clin Exp Med. 2014 Dec 15;7(12):4759-69. eCollection 2014.
3
Pirfenidone treatment of idiopathic pulmonary fibrosis.吡非尼酮治疗特发性肺纤维化。
Ther Clin Risk Manag. 2011 Feb 8;7:39-47. doi: 10.2147/TCRM.S12209.
4
Clinical use of biomarkers of survival in pulmonary fibrosis.肺纤维化中生存生物标志物的临床应用。
Respir Res. 2010 Jun 28;11(1):89. doi: 10.1186/1465-9921-11-89.
5
Pulmonary function testing in idiopathic interstitial pneumonias.特发性间质性肺炎的肺功能测试
Proc Am Thorac Soc. 2006 Jun;3(4):315-21. doi: 10.1513/pats.200602-022TK.
6
The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.成人弥漫性实质性肺疾病的诊断、评估与治疗。引言。
Thorax. 1999 Apr;54 Suppl 1(Suppl 1):S1-14. doi: 10.1136/thx.54.suppl_1.s1.